Image

Neuroprotection Bundles For Comatose Survivors Following Cardiac Arrest

Neuroprotection Bundles For Comatose Survivors Following Cardiac Arrest

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The investigators designed LAPTOPS to determine the effectiveness of a goal-directed neuroprotection bundles of active management including body temperature,PaCO2,PaO2,position,Blood glucose ,blood sodium,Blood pressure and Lactate vs. usual care in adult post-cardiac arrest care.

LAPTOPS is a large-scale pragmatic clinical trial to provide reliable evidence over the effectiveness of a widely applicable goal-directed care bundle in acute phase of adult post-cardiac arrest care.

Eligibility

Inclusion Criteria:

  • Age ≥ 18 years and \< 80 years
  • Patients of in-hospital or out-of-hospital cardiac arrest who have returned -spontaneous circulation (ROSC) after cardiopulmonary resuscitation and do not require CPR for more than 20 minutes;
  • Patients who are unconscious after ROSC, defined as FOUR motor response score \< 4 points or GSC ≤ 8 points;
  • Family members or legal representatives signed informed consent.

Exclusion Criteria:

  • Unwitnessed cardiac arrest, estimated time from cardiac arrest to start of CPR \> 30 minutes;
  • Time from cardiac arrest to ROSC \> 60 minutes;
  • Patients who woke up immediately after ROSC by CPR;
  • End-stage diseases;
  • Cardiac arrest considered to be caused by neurological diseases;
  • The patient was in a vegetative state before cardiac arrest;
  • The interval from the onset of cardiac arrest to enrollment is \>72 hours .

Study details
    Cardiac Arrest
    Post-cardiac Arrest Care

NCT06992843

Xiangya Hospital of Central South University

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.